In the Longest-Running Post-Marketing Surveillance Study of Its Type, Data at 24 Months on FDgard®, Presented at The American College of Gastroenterology (ACG) Annual Meeting, Confirms Excellent Safety and Tolerability Profile of This Nonprescription Product for Functional Dyspepsia (Meal-Triggered, Recurring Indigestion)
Source: FDgardPublished on 2019-10-29